Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indian Council of Medical Research's network of pulmonary fibrosis (INPF): A big step forward towards understanding interstitial lung diseases in India.

Lung India : official organ of Indian Chest Society·2026
Same author

Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).

BMJ (Clinical research ed.)·2026
Same author

Microfilaria: A Microscopic Baby Dance.

Clinical case reports·2026
Same author

Are iris masses in lung carcinoma always a metastasis: Two case reports.

World journal of methodology·2026
Same author

Methodological issue in a dental neuromelioidosis outbreak investigation.

The Lancet regional health. Southeast Asia·2026
Same author

Agreement between the one-minute sit-to-stand test and the six-minute walk test in assessing exercise capacity in patients with interstitial lung disease.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2025

Related Experiment Video

Updated: Jun 15, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculous lymphadenitis.

Prasanta Raghab Mohapatra1, Ashok Kumar Janmeja

  • 1Department of Pulmonary Medicine, Government Medical College and Hospital, Chandigarh, India.

The Journal of the Association of Physicians of India
|March 10, 2010
PubMed
Summary
This summary is machine-generated.

Tuberculosis lymphadenitis, a common extrapulmonary form, presents diagnostic and treatment challenges. Early diagnosis and differentiating it from other mycobacterial infections are crucial for effective management.

Related Experiment Videos

Last Updated: Jun 15, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Lymphadenitis is the most frequent extrapulmonary manifestation of tuberculosis (TB).
  • It poses diagnostic and therapeutic challenges due to its mimicry of other conditions and inconsistent clinical findings.
  • Distinguishing tuberculous from nontuberculous mycobacterial cervical lymphadenitis is critical due to differing treatment protocols.

Purpose of the Study:

  • To highlight the diagnostic and therapeutic complexities of tuberculous lymphadenitis.
  • To emphasize the importance of early diagnosis and differentiation from other mycobacterial infections.
  • To discuss current challenges including atypical mycobacteria, HIV, and drug-resistant TB.

Main Methods:

  • Review of clinical presentation, diagnostic methods (history, physical exam, AFB staining, FNA, PCR), and treatment strategies for TB lymphadenitis.
  • Emphasis on differentiating tuberculous from nontuberculous mycobacterial causes.
  • Consideration of factors complicating management, such as HIV and drug resistance.

Main Results:

  • Diagnosis often requires biopsy due to nonspecific findings.
  • A combination of clinical evaluation and microbiological tests aids early diagnosis.
  • Treatment monitoring is complex due to the unique behavior of TB lymph nodes.

Conclusions:

  • Tuberculous adenitis should be managed as a systemic disease using antituberculosis medication.
  • Surgical intervention may be beneficial in select cases alongside medical therapy.
  • The rising incidence of atypical mycobacteria, HIV, and drug-resistant TB complicates the management landscape.